Key statistics
As of last trade ADMA Biologics Inc (ADMA:NMQ) traded at 21.36, -9.64% below its 52-week high of 23.64, set on Nov 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 21.45 |
---|---|
High | 21.48 |
Low | 20.88 |
Bid | 21.35 |
Offer | 21.36 |
Previous close | 21.30 |
Average volume | 3.08m |
---|---|
Shares outstanding | 236.39m |
Free float | 227.20m |
P/E (TTM) | 77.08 |
Market cap | 5.04bn USD |
EPS (TTM) | 0.2763 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 20:37 GMT.
More ▼
- ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update
- ADMA Biologics to Report Third Quarter 2024 Financial Results on November 7, 2024
- ADMA Biologics Set to Join S&P SmallCap 600 Index
- ADMA Biologics to Participate in the 2024 Cantor Global Healthcare Conference
- ADMA Biologics Announces Partial Paydown of Revolving Credit Facility
- ADMA Biologics Announces Second Quarter 2024 Financial Results and Provides Business Update
- ADMA Biologics to Report Second Quarter 2024 Financial Results on August 8, 2024
- ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update
- ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024
- ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®
More ▼